This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arlen, P. A.
Right arrow Articles by Zack, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arlen, P. A.
Right arrow Articles by Zack, J. A.

 Previous Article  |  Next Article 

Journal of Virology, February 2006, p. 1599-1603, Vol. 80, No. 3
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.3.1599-1603.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Rapid Expression of Human Immunodeficiency Virus following Activation of Latently Infected Cells

Philip A. Arlen,1 David G. Brooks,2,{dagger} Lian Y. Gao,2 Dimitrios Vatakis,2 Helen J. Brown,1 and Jerome A. Zack1,2*

Department of Microbiology, Immunology, and Molecular Genetics,1 Department of Medicine and AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles, 11-934 Factor Building, 650 Charles Young Drive South, Los Angeles, California 900952

Received 22 August 2005/ Accepted 7 November 2005

The host cell activation state impacts the nature of human immunodeficiency virus infection. Activated cells facilitate productive infections; quiescent cells enable the virus to enter a latent state, the major obstacle to viral clearance. We wanted to understand how these differences affected viral gene expression. In quiescent cells activated prior to infection, viral RNA was seen 12 h postinfection; when cells were stimulated postinfection, viral RNA was not seen until 36 h postinfection. Up-regulation of viral RNA in latently infected cells occurred within 2 h poststimulation. This hierarchy also held true for viral protein production. These results may explain the rapid reemergence of viremia following termination of therapy.


* Corresponding author. Mailing address: David Geffen School of Medicine, University of California, Los Angeles, 11-934 Factor Building, 650 Charles Young Drive South, Los Angeles, CA 90095. Phone: (310) 825-0876. Fax: (310) 825-6192. E-mail: jzack{at}ucla.edu.

{dagger} Present address: Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037.


Journal of Virology, February 2006, p. 1599-1603, Vol. 80, No. 3
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.3.1599-1603.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Pearson, R., Kim, Y. K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M., Karn, J. (2008). Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency. J. Virol. 82: 12291-12303 [Abstract] [Full Text]  
  • Poon, B., Chang, M. A., Chen, I. S. Y. (2007). Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA. J. Virol. 81: 10515-10523 [Abstract] [Full Text]  
  • Vatakis, D. N., Bristol, G., Wilkinson, T. A., Chow, S. A., Zack, J. A. (2007). Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells. J. Virol. 81: 3574-3582 [Abstract] [Full Text]  
  • Stevens, M., Pollicita, M., Pannecouque, C., Verbeken, E., Tabarrini, O., Cecchetti, V., Aquaro, S., Perno, C. F., Fravolini, A., De Clercq, E., Schols, D., Balzarini, J. (2007). Novel In Vivo Model for the Study of Human Immunodeficiency Virus Type 1 Transcription Inhibitors: Evaluation of New 6-Desfluoroquinolone Derivatives. Antimicrob. Agents Chemother. 51: 1407-1413 [Abstract] [Full Text]